Generating a T cell tumor-specific immune response in vivo: can flt3-ligand-generated dendritic cells tip the balance?

Autor: McKenna, H. J.

Publikováno v: Cancer Immunology, Immunotherapy; Aug1999, Vol. 48 Issue 6, p281-286, 6p

Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death.

Autor: Ware, C B, Horowitz, M C, Renshaw, B R, Hunt, J S, Liggitt, D, Koblar, S A, Gliniak, B C, McKenna, H J, Papayannopoulou, T, Thoma, B

Publikováno v: Development; May 1995, Vol. 121 Issue: 5 p1283-99, 17p

#338 Improved survival in murine rhabdomyosarcoma by FLT 3 ligand enhanced CD4+ and CD8+ T-cell infiltration of tumors.

Autor: Weigel, B. J., Mortari, A. Panoskaltsis, Evans, R., Braun, S. E., Cometta, K., Basso, L., Mckenna, H. J., Blazar, B.

Publikováno v: Journal of Pediatric Hematology/Oncology; Jul/Aug1999, Vol. 21 Issue 4, p318-318, 1p

Flt3 ligand (FL) treatment of murine donors does not modify graft-versus-host disease (GVHD) but FL treatment of recipients post-bone marrow transplantation accelerates GVHD lethality.

Autor: Blazar BR; Cancer Center and the Department of Pediatrics, Fairview-University of Minnesota Hospital and Clinics, Minneapolis, USA. blaza001@tc.umn.edu, McKenna HJ, Panoskaltsis-Mortari A, Taylor PA

Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2001; Vol. 7 (4), pp. 197-207.

Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand.

Autor: Daro E; Department of Immunobiology, Research Administration, and Analytical Chemistry and Formulation, Immunex Corporation, Seattle, WA 98101, USA., Pulendran B, Brasel K, Teepe M, Pettit D, Lynch DH, Vremec D, Robb L, Shortman K, McKenna HJ, Maliszewski CR, Maraskovsky E

Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2000 Jul 01; Vol. 165 (1), pp. 49-58.